Viking’s $125 Million PIPE Investment in ORIC

Cleary Gottlieb represented Viking Global Investors in the transaction. Viking Global Investors (Viking) executed a PIPE investment in ORIC Pharmaceuticals, Inc. (ORIC), a clinical-stage biopharmaceutical company dedicated…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here